Literature DB >> 10469450

A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas.

B Kazmierczak1, K Meyer-Bolte, K H Tran, W Wöckel, I Breightman, J Rosigkeit, S Bartnitzke, J Bullerdiek.   

Abstract

Pulmonary chondroid hamartomas (PCHs) are benign mesenchymal tumors that often are characterized by specific chromosomal aberrations. Herein we report our cytogenetic and molecular cytogenetic (FISH) studies on 191 PCHs, including 48 previously published cases. In this series, 134/191 PCHs (70.2%) showed either abnormalities of chromosomal bands 6p21 (21 tumors), 12q14-15 (95 tumors), or had other abnormalities (18 tumors). Two tumors had a 6p21 aberration together with a 12q14-15 aberration. The most frequent translocations were t(12;14)(q15;q24) (19 cases) and t(6;14)(p21. 3;q24) (18 cases), both in either simple or complex form. By FISH with cosmids spanning the gene encoding the high-mobility-group protein HMGIC, we were able to show a rearrangement within or close to HMGIC in all tumors with 12q14-15 abnormalities tested, in 11 tumors with an apparently normal karyotype, and in 4 tumors with complex abnormalities without cytogenetically visible alterations of chromosomes 12. Rearrangements of HMGIY or its immediate surroundings were shown for 21 cases with 6p21 aberrations and three cases with other chromosomal abnormalities but without cytogenetically visible alterations of chromosomes 6. Genes Chromosomes Cancer 26:125-133, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469450

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

Review 2.  Ring chromosomes: from formation to clinical potential.

Authors:  Inna E Pristyazhnyuk; Aleksei G Menzorov
Journal:  Protoplasma       Date:  2017-09-12       Impact factor: 3.356

3.  Fusion of the HMGA2 and NFIB genes in lipoma.

Authors:  M Nilsson; I Panagopoulos; F Mertens; N Mandahl
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

Review 4.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

5.  HMGA2 expression in white adipose tissue linking cellular senescence with diabetes.

Authors:  Dominique Nadine Markowski; Helge Wilhelm Thies; Andrea Gottlieb; Heiner Wenk; Manfred Wischnewsky; Jörn Bullerdiek
Journal:  Genes Nutr       Date:  2013-07-24       Impact factor: 5.523

6.  Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Marius Lund-Iversen; Ingvild Lobmaier; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

7.  A novel truncated form of HMGA2 in tumors of the ovaries.

Authors:  Antonio Agostini; Ioannis Panagopoulos; Ben Davidson; Claes Goran Trope; Sverre Heim; Francesca Micci
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

8.  HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.

Authors:  W Czyz; E Balcerczak; M Jakubiak; Z Pasieka; K Kuzdak; M Mirowski
Journal:  Langenbecks Arch Surg       Date:  2004-04-24       Impact factor: 3.445

9.  Intrapulmonary solitary fibrous tumor diagnosed by immunohistochemical and genetic approaches: report of a case.

Authors:  Motoyasu Sagawa; Yoshimichi Ueda; Fujitsugu Matsubara; Hiroshi Sakuma; Yutaka Yoshimitsu; Hirokazu Aikawa; Katsuo Usuda; Hiroshi Minato; Tsutomu Sakuma
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

Review 10.  Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.

Authors:  Linda Resar; Lionel Chia; Lingling Xian
Journal:  Cancer Res       Date:  2018-04-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.